| Date Filed | Type | Description |
| 02/16/2010 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 07/01/2009 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/22/2009 |
25
| Form 25 -- Notification of the removal from listing and registration of matured, redeemed or retired securities |
| 06/18/2009 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals |
| 06/12/2009 |
8-K
| Quarterly results |
| 06/12/2009 |
15-12G
| Form 15-12G -- Securities registration termination [Section 12(g)] |
| 06/10/2009 |
8-K
| Results of Operations and Financial Condition, Financial Statements and Exhibits |
| 06/09/2009 |
4
| Xmark Opportunity Partners, LLC (10% Owner) has filed a Form 4 on GENAERA CORP |
| 05/27/2009 |
8-K
| Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Other Events, Financial ... |
| 05/14/2009 |
DEFM14A
| Form DEFM14A - Definitive proxy statement relating to merger or acquisition: |
| 05/14/2009 |
PRER14A
| Form PRER14A -- Preliminary Proxy Soliciting materials |
| 05/06/2009 |
SC 13G
| Form SC 13G -- Statement of acquisition of beneficial ownership by individuals |
| 04/29/2009 |
8-K
| Form 8-K -- Current report |
| 04/28/2009 |
PRE 14A
| Form PRE 14A -- Other preliminary proxy statements |
| 04/28/2009 |
8-K
| Entered into consulting agreement |
| 04/03/2009 |
8-K/A
| Form 8-K/A -- Current report [amend] |
| 04/03/2009 |
8-K
| Entered into consulting agreement |
| 03/30/2009 |
8-K
| Other Events, Financial Statements and Exhibits |
| 03/10/2009 |
8-K
| Form 8-K -- Current report |
| 03/05/2009 |
4
| Xmark Opportunity Partners, LLC (10% Owner) has filed a Form 4 on GENAERA CORP |
| 03/04/2009 |
8-K
| Form 8-K -- Current report |
| 03/03/2009 |
10-K
| Annual Report for the period ended December 31, 2008 |
| 02/23/2009 |
4
| Kaye Mitchell D (10% Owner) has filed a Form 4 on GENAERA CORP |
| 02/10/2009 |
8-K
| Form 8-K -- Current report |
| 02/05/2009 |
8-K
| Other Events, Financial Statements and Exhibits|
Docs:
|
"Genaera to Present at BIO CEO & Investor Conference Plymouth Meeting, Pa. - February 5, 2009 - Genaera Corporation will present at the Eleventh Annual BIO CEO & Investor Conference, being held February 9-10, at the Waldorf-Astoria Hotel in New York. Jack Armstrong, President and Chief Executive Officer, will provide promising preliminary Phase 1b clinical data for MSI-1436, the first-in-class, highly selective inhibitor of PTP1B and Genaera's lead drug candidate for the treatment of type 2 diabetes and obesity, on Tuesday, February 10, 2009 at 2:15 p.m. . About Genaera Genaera Corporation is developing trodusquemine , for type 2 diabetes and obesity currently in phase 1 clinical testing and has a fully out-licensed partnership with MedImmune, Inc. that is in phase 2 clinical testing in ast..." |
|
| 01/27/2009 |
SC 13G/A
| Form SC 13G/A -- Statement of acquisition of beneficial ownership by individuals [amend] |
| 01/22/2009 |
8-K
| Form 8-K -- Current report |
| 12/24/2008 |
8-K
| Form 8-K -- Current report |
| 12/04/2008 |
8-K
| Other Events, Financial Statements and Exhibits |
| 11/14/2008 |
10-Q
| Quarterly Report for the period ended September 30, 2008 |
| 11/14/2008 |
8-K
| Quarterly results |
| 11/13/2008 |
8-K
| Form 8-K -- Current report |
| 11/06/2008 |
8-K
| Form 8-K -- Current report |
| 10/31/2008 |
8-K
| Other Events, Financial Statements and Exhibits |
|